C. Staiger

发表

The pharmacokinetic and pharmacodynamic profiles of the thromboxane A‐2 receptor blocker BM 13.177

B. Kaufmann, H. Patscheke, C. Staiger, 1986, Clinical pharmacology and therapeutics.

Irbesartan in patients with heart failure and preserved ejection fraction.

Susan Anderson, Mark Donovan, R. McKelvie, 2008, The New England journal of medicine.

Dronedarone in high-risk permanent atrial fibrillation.

D. Atar, S. Yusuf, Jun Zhu, 2011, The New England journal of medicine.

Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives

M. Hennig, C. Staiger, L. Widmann, 2005, European Journal of Clinical Pharmacology.

Inhibition of drug metabolism by the antimalarial drugs chloroquine and primaquine in the rat.

A. Breckenridge, D. Back, C. Staiger, 1983, Biochemical pharmacology.

Abstract 3146: The Relation of Quality of Life Score to Outcome in Heart Failure With Preserved Ejection Fraction: Findings From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial (I-PRESERVE)

R. McKelvie, J. McMurray, M. Komajda, 2009 .

Pharmacokinetics of the thromboxane A2 receptor antagonist sulotroban (BM 13.177) in renal failure.

B. Kaufmann, C. Staiger, K. Stein, 1989, British journal of clinical pharmacology.

The effects of a combination of cigarette smoking and oral contraception on coagulation and fibrinolysis in human females

C. Staiger, J. Harenberg, E. Weber, 1985, Klinische Wochenschrift.

Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.

H. Patscheke, C. Staiger, G. Neugebauer, 1984, Biomedica biochimica acta.

Lack of effect of cimetidine on action of phenprocoumon

C. Staiger, J. Harenberg, E. Weber, 1982, European Journal of Clinical Pharmacology.

Single dose pharmacokinetics and effects on platelet function of the thromboxane receptor blocker BM 13.177

B. Kaufmann, H. Patscheke, C. Staiger, 2004, European Journal of Clinical Pharmacology.

Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol

U. Gundert-Remy, C. Staiger, J. Harenberg, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics of sulphinpyrazone and its major metabolites after a single dose and during chronic treatment

U. Gundert-Remy, C. Staiger, J. Harenberg, 2004, European Journal of Clinical Pharmacology.

Analysis of sulfinpyrazone and its metabolites in human plasma and urine by high-performance liquid chromatography.

C. Staiger, J. D. de Vries, N. S. Wang, 1983, Journal of chromatography.

The effects of ampicillin on oral contraceptive steroids in women.

P H Rowe, A. Breckenridge, D. Back, 1982, British journal of clinical pharmacology.

Simultaneous determination of antipyrine and metabolites in human plasma and urine by high-performance liquid chromatography.

C. Staiger, N. S. Wang, B. Koroknay, 1984, Journal of chromatography.

Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study

D. DeMets, J. Rouleau, H. Krum, 2002, Circulation.

Induction of drug metabolizing enzymes by sulfinpyrazone

C. Staiger, E. Weber, R. Zimmermann, 2004, European Journal of Clinical Pharmacology.

Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers [letter]

C. Staiger, E. Weber, P. Müller, 1984 .

Comparative effects of ICI 125,211 and cimetidine on antipyrine kinetics

C. Staiger, H. Kather, J. A. D. Vries, 1981 .

Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I‐PRESERVE trial

R. McKelvie, J. McMurray, M. Komajda, 2008, European journal of heart failure.

Enhanced drug metabolism after sulfinpyrazone treatment in patients aged 50 to 60 years

C. Staiger, E. Weber, M. Degott, 1982, Klinische Wochenschrift.

A Rapid and Sensitive Method for the Determination of Phenazone (Antipyrine®) using Gas-Liquid-Chromatography with Nitrogen Detection

C. Staiger, E. Walter, J. de Vries, 1980, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Double-Blind, Controlled Clinical Trial to Evaluate the Antihypertensive Effect of Carvedilol in Elderly Patients with Mild to Moderate Hypertension

C. Staiger, B. Ehmer, W. Holtbrügge, 1988, Drugs.

Influence of amiodarone on antipyrine pharmacokinetics in three patients with ventricular tachycardia.

C. Staiger, J. de Vries, E. Weber, 1984, British journal of clinical pharmacology.

Treatment of digitalis intoxication with digoxin-specific Fab antibody fragments.

P. Wahl, C. Staiger, J. Harenberg, 1983, The New England journal of medicine.

Inhibition of Platelet Activation in Man by the Selective Thromboxane Receptor Antagonist BM 13.177

H. Patscheke, C. Staiger, G. Neugebauer, 1985 .

Cimetidine does not increase the anticoagulant effect of phenprocoumon.

C. Staiger, J. Harenberg, E. Weber, 1982, British journal of clinical pharmacology.

INHIBITION OF PLATELET ACTIVATION BY THE NOVEL THROMBOXANE RECEPTOR ANTAGONIST BM 13.505

H. Patscheke, C. Staiger, G. Neugebauer, 1987, Thrombosis and Haemostasis.

Dronedarone in high-risk permanent atrial fibrillation.

D. Atar, S. Yusuf, D. Xavier, 2011, The New England journal of medicine.

Influence of ranitidine on antipyrine pharmacokinetics in healthy volunteers

C. Staiger, H. Kather, B. Simon, 1980, Digestive Diseases and Sciences.